Asset Publisher

null Unit AIDS Research Network Cohort (CoRIS)

Centro Nacional de Epidemiología (ISCIII)/Centro Sanitario Sandoval, Madrid


The AIDS Research Network Cohort was established in 2004 together with the HIV Biobank. These platforms are unique data resources that enhance the knowledge about HIV and provides information to answer research questions about the epidemic.

The CoRIS coordination centre is at the National Centre of Epidemiology within the Instituto de Salud Carlos III campus in Charmartín, Madrid. The coordination team is a multidisciplinary group of 15 professionals: epidemiologists, statisticians, clinicians, pharmacists…

CoRIS main objective is to collect information about HIV positive patients to study the epidemiological characteristics, the infection progression and its determinants as well as the treatment response and its influencing factors.

CoRIS follows up more than 12.000 HIV positive persons from 45 health centres and hospitals in 13 regions in Spain, which facilitates a close follow up of the epidemic in sociodemographic and clinical aspects.

CoRIS is organized around three structures:

  • Coordination centre: Organizes and coordinates data collection, supporting hospitals in these procedures and facilitating data treatment for statistical analyses and articles’ writing.
  • Clinical centres: hospital and health centres. They collect the information and biological samples. They formulate research questions.
  • CoRIS Scientific Committee: Its members decide about the cohort scientific development. It also evaluates applications from research groups that need to use CoRIS data in their projects.

CoRIS is actively involved in international groups and networks such as:

  • HIV-CAUSAL collaboration.
  • ART Cohort Collaboration.
  • ECDC (European Center for Disease Control and Prevention).
  • IeDEA International epidemiology Databases to Evaluate AIDS.
  • Anti-HIV Drug Resistance Network.

You can download her Quality politics (spanish)

Related Assets


Inmaculada Jarrín
Oscar Ayerdi
Juan Ballesteros
Jorge del Romero
Asunción Díaz
Victoria Hernando
Carlos Iniesta
Cristina Moreno
Julián Alexander Portocarrero
Teresa Puerta
Carmen Rodríguez
Marta Ruiz
Inés Suárez
Marta Rava
Rebeca Izquierdo

Related Assets

Related Assets


  • Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study. 
    Alejos B, Suárez-García I, Rava M, Bautista-Hernández A, Gutierrez F, Dalmau D, Sagastagoitia I, Rivero A, Moreno S, Jarrín I; CoRIS.  J Antimicrob Chemother. 2020 Jul 15:dkaa246. doi: 10.1093/jac/dkaa246. Online ahead of print.PMID: 32667674 
  • Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study. 
    Del Amo J, Polo R, Moreno S, Díaz A, Martínez E, Arribas JR, Jarrín I, Hernán MA; The Spanish HIV/COVID-19 Collaboration.  Ann Intern Med. 2020 Jun 26:M20-3689. doi: 10.7326/M20-3689. Online ahead of print.PMID: 32589451 
  • AIDS All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas. 
    Jarrín I, Hanna DB, Nash D, Yiannoutsos CT, Porter K, Cornell M, Dabis F, Musick B, Phillips A, Mocroft A, Jaquet A, Rebeiro P, Luz P, Giles M, Sohn A, Althoff K, Moore R, Wools-Kaloustian K, Egger M, Anastos K, del Amo J; IeDEA and COHERE in EuroCoord Cohort Collaboration.  AIDS 2020 Feb 1;34(2):277-289. doi: 10.1097/QAD.0000000000002399.PMID: 31876592 
  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. 
    Rodger AJ, Cambiano V, Phillips AN, et al.  Lancet. 2019;393(10189):2428-2438. doi:10.1016/S0140-6736(19)30418-0 
  • Natural Conception is Safe for HIV-Serodiscordant Couples with Persistent Suppressive Antiretroviral Therapy for the Infected Partner. 
    Baza MB, Jerónimo A, Río I, et al.  J Women’s Heal. 2019;28(11):1555-1562. doi:10.1089/jwh.2018.748 
  • Estimating the number of people living with HIV and the undiagnosed fraction in Spain in 2013. 
    Nuñez O, Hernando V, Diaz A.  AIDS. 2018;32(17):2573-2581. doi: 10.1097/QAD.0000000000001989. 
  • Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population? 
    Vourli G, Pharris A, Cazein F, Costagliola D, Dabis F, Del Amo J, Delpech V, Díaz A, Girardi E, Gourlay A, Gunsenheimer-Bartmeyer B, Hernando V, Nikolopoulos G, Porter K, Rosińska M, Sabin C, Suligoi B, Supervie V, Wit F, Touloumi G.  AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002034 
  • Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017. 
    Iniesta C, Álvarez-del Arco D, García-Sousa LM, et al.  Lima VD, ed. PLoS One. 2018;13(10):e0204738. doi:10.1371/journal.pone.0204738 
  • Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? 
    Jarrín I, Monge S, Mocroft A, Sabin A, Touloumi G, Sighem A, Abgrall S, Dray-Spira R, Spire B, Castagna A, Mussini C, Zangerle R, Hessamfar M, Anderson J, Hamouda O, Ehren K, Obel N, Kirk O, Antinori A, Girardi E, Saracino A, Calmy A, Wit S, Wittkop L, Bucher C, Montoliu A, Raben D, Prins M, Meyer L, Chene G, Burns F, Amo J, Judd A, Zangerle R, Touloumi G, Warszawski J, Meyer L, Dabis F, Krause M, Ghosn J, Leport C, Wittkop L, Reiss P, Wit F, Prins M, Bucher H, Gibb D, Fätkenheuer G, Amo J.  HIV Med. 2017 Jul 25. doi: 10.1111/hiv 
  • Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe. 
    del Amo J, Lodi S, Dray-Spira R, Wittkop L, Monge S, Braun D, Vehreschild J, Teira R, Campbell C, d’Arminio Monforte A, Zangerle R, Ghosen J, Kourkounti S, Dabis F, Leport C, Meyer L, Termote M, Kirk O, Porter K, Spire B, Chene G, Egger M.  AIDS. 2017 Jan 14;31(2):253-262. doi: 10.1097/QAD.0000000000001270. 

Related Assets